Corrigendum to "Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban" [Vascular Pharmacology 124 (2020)/106608].
Ferreira T, Huber SC, de Moraes Martinelli B, Junior AL, Menezes FH, Orsi FA, Bittar LF, de Oliveira LFG, Sodre LR, Mello TT, Rielli G, Colella MP, de Paula EV, Yamaguti Hayakawa GG, Montalvão S, Annichino-Bizzacchi JM.
Ferreira T, et al. Among authors: huber sc.
Vascul Pharmacol. 2020 Oct-Nov;133-134:106780. doi: 10.1016/j.vph.2020.106780. Epub 2020 Aug 28.
Vascul Pharmacol. 2020.
PMID: 32868216
No abstract available.